Bruno Farmaceutici S.p.A. is a dynamic Italian pharmaceutical company whose aim has always been improving people’s health and well-being through the development, production, and distribution of drugs with the highest standards of quality, safety, and efficiency.
The company is a market leader for solid oral corticosteroids and anti-diabetes medicines. Its portfolio also includes medicines for cardiovascular diseases, infections, rheumatology diseases, and bone metabolism disorders.
Thanks to its dynamic approach, Bruno Farmaceutici recently started developing advanced formulations for the treatment of osteoporosis, chronic and acute pain, and alcohol addiction.
Today, we are a very dynamic company with over 150 employees and a strategic position in orthopaedics, rheumatology, ENT, paediatrics, cardiology, primary care, and obviously diabetology, a field with high growth potential. Moreover, our ophthalmology solutions are particularly innovative and appreciated. They are offered by Safilens, an integral part of the Bruno Farmaceutici Group.
Although Bruno Farmaceutici wants to cultivate its Italian roots, in recent years it has started an ambitious internationalization project thanks to which we have entered the main European pharmaceutical markets.